OncoImmune
Prior to joining OncoImmune, Dr. Devenport was VP for Business Strategy at Amplimmune Inc., where he oversaw all project management and operational activities, as well as business development, contracts and intellectual property. Dr. Devenport is experienced with all aspects of the drug development process, including research, development, GMP manufacturing, regulatory and clinical trials, and has managed a number of biotechnology programs that reached clinical stage development in oncology and autoimmune indications.
This person is not in the org chart
This person is not in any offices
OncoImmune
Based in Rockville, Maryland, OncoImmune is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biopharmaceuticals for the treatment of cancer and autoimmune disease.